BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset Management, according to people familiar with the matter.
BC Partners Nears Sale of Synthon to Goldman Asset Arm
Estimated read time
1 min read
You May Also Like
TSMC Shares Touch Record High, Eying Best Year Since 1999 on AI
December 24, 2024
Bitcoin Momentum Ebbs Heading Into Last Stretch of Record Year
December 24, 2024
UK launches review of targets for sales of electric vehicles
December 24, 2024
More From Author
Your complete guide to travel protection on American Express cards
December 24, 2024
2024’s funniest and most WTF moments | Ents & Arts News
December 24, 2024
Brandon Sklenar Speaks Out on Blake Lively’s Justin Baldoni Complaint
December 24, 2024
+ There are no comments
Add yours